Evaluation of respiratory complications in a cohort of preterm infants who did not receive palivizumab monoclonal antibodies.

Poliana Castro de Resende Bonati Maria Cândida de Carvalho Furtado Débora Falleiros de Mello Paula Carolina Bejo Wolkers Gabriel de Oliveira Faria Daniela Marques de Lima Mota Ferreira

Published in: Revista brasileira de enfermagem (2022)

preterm infants who did not receive palivizumab showed a high percentage of respiratory diseases, and breastfeeding helped protect them against bronchiolitis. It is recommended that these preterm babies be monitored in primary health care.

Keyphrases

preterm infants
low birth weight
respiratory syncytial virus
gestational age
respiratory tract
preterm birth
risk factors